Trendlines portfolio company Phytolon closes US$ 23.6 million Series B financing

  • Trendlines portfolio company Phytolon closed a US$ 23.6 million Series B to commercialize fermentation-based natural food colors in the U.S.
  • Round was led by an undisclosed strategic investor; existing backers participated.
  • FDA clearance for Phytolon’s Beetroot Red was obtained; the final rule’s effective date has not been set.
  • Phytolon cited strategic investors including DSM Venturing, Colorcon Ventures, Rich Products Ventures; it also works with Ginkgo Bioworks.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Trendlines Group Ltd. published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: 4G67YTUL8E2V1SBZ) on May 28, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.